Market Research Logo

Malaysia Pharmaceuticals and Healthcare Report Q3 2015

140 Pages BMI Research July 08, 2015 SKU: BMI5621730

BMI View: Despite the decline in oil prices impacting government spending, we believe the Malaysiangovernment will be able to maintain its commitment to the country's healthcare sector as it continuesdiversification of its revenue base. Moreover, healthcare provision remains critical to the governmentwhich will limit reductions that affect medical services. However, commercial opportunities for innovativedrugmakers continue to be weighed down by low levels of intellectual property protection, theimplementation of a Goods and Service Tax (GST) as well as the preferential treatment of localdrugmakers.

Headline Expenditure Projections

Pharmaceuticals: MYR7.22bn (USD2.21bn) in 2014 to MYR7.88bn (USD2.13bn) in 2015; +9.2% inlocal currency and -3.4% in US dollar terms.

Healthcare: MYR42.75bn (USD13.06bn) in 2014 to MYR46.13bn (USD12.47bn) in 2015; +7.9% inlocal currency and -4.6% in US dollar terms.

Show Full Description


Show Table of Contents



Malaysia Pharmaceuticals and Healthcare Report Q3 2015

BMI Research
July 08, 2015

Pricing & Delivery

Report with 3 quarterly updates
$1,295
Report with 3 quarterly updates - 3 User License
$1,945
Report with 3 quarterly updates - 5 User License
$2,500
Report with 3 quarterly updates - Departmental/Site License
$2,995
Global Site License Fulfilled by Publisher
$6,995

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report